Ophthalmic Laser Industry to Reach USD 1,561.0 Million by 2034 at a 4.8% of CAGR, Driven by Rising Prevalence of Eye Disorders and Non-Invasive Treatments

Ophthalmic Laser Industry
Ophthalmic Laser Industry

The global ophthalmic laser market is set to experience steady growth, with sales estimated to increase from USD 976.8 million in 2024 to USD 1,561.0 million by 2034, representing a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The market revenue in 2023 stood at USD 932.1 million, underscoring the growing adoption of advanced ophthalmic laser technologies.

This growth is attributed to the rising prevalence of ophthalmic disorders, including cataracts, glaucoma, macular degeneration, and retinal diseases. These conditions are driving demand for non-invasive, energy-based treatment options that offer enhanced precision and reduced recovery times. Advances in laser technologies, such as femtosecond lasers and Selective Laser Trabeculoplasty (SLT), are contributing to improved patient outcomes by minimizing invasiveness and increasing treatment accuracy.

As healthcare providers and patients prioritize safe, effective, and non-invasive treatment modalities, ophthalmic lasers are becoming a cornerstone of modern ophthalmology. The increasing emphasis on early diagnosis and intervention for eye disorders further bolsters market expansion.

Full Report Revealed – https://www.futuremarketinsights.com/reports/ophthalmic-lasers-therapeutic-market

Key Takeaways:

  • The global ophthalmic laser market is projected to grow from USD 976.8 million in 2024 to USD 1,561.0 million by 2034 at a CAGR of 4.8%.
  • Rising incidences of eye disorders such as cataracts, glaucoma, and retinal diseases are key market drivers.
  • Non-invasive laser treatments like femtosecond lasers and SLT are enhancing treatment precision and improving patient outcomes.
  • Growing global awareness of the importance of early diagnosis and minimally invasive treatments is fueling market demand.

With ongoing advancements in laser technologies and increasing global demand for effective ophthalmic treatments, the ophthalmic laser market is set to play a vital role in addressing the challenges posed by rising vision disorders worldwide.

Key Market Drivers

  1. Increasing Prevalence of Ophthalmic Disorders: The rise in conditions such as cataracts, glaucoma, macular degeneration, and retinal disorders is driving demand for ophthalmic lasers. As these disorders become more common, the need for effective treatment options increases.
  2. Preference for Non-Invasive Treatments: There is a significant shift towards non-invasive energy-based treatment options, which are less traumatic for patients and often result in quicker recovery times.
  3. Technological Advancements: Improvements in laser technology, including femtosecond lasers and selective laser trabeculoplasty (SLT), enhance precision and minimize invasiveness, leading to better patient outcomes.
  4. Growing Awareness and Accessibility: Increased awareness about eye health and advancements in healthcare infrastructure are making ophthalmic treatments more accessible to a broader population.
  5. Rising Geriatric Population: An aging population is more susceptible to vision-related disorders, further driving the demand for ophthalmic laser treatments.

Market Insights

  • The revenue generated by ophthalmic lasers in 2023 was approximately USD 932.1 million, indicating solid growth momentum leading into the forecast period.
  • The market is characterized by a variety of applications including refractive error correction, cataract surgery, diabetic retinopathy treatment, and glaucoma management.

Regional Insights

  • North America is expected to dominate the market due to advanced healthcare systems and high adoption rates of new technologies.
  • Emerging markets in Asia-Pacific are anticipated to experience significant growth due to increasing healthcare investments and rising awareness about eye care.

Competitive Landscape

The ophthalmic lasers market is diversified by multiple active game players, and innovators, concerning the emerging demands of healthcare providers and patients. Thus, with the surging demand for more sophisticated eye care treatments, companies are focusing on the intense research and development of laser-based technologies that could be better at delivering positive patient outcomes and more efficient surgeries.

This recent competitive environment has then become their means to expand their portfolios of products and raise their market share through strategic partnerships, mergers, and acquisitions. Emerging new entrants and technological changes in the market are always shaping the market dynamics.

Recent Industry Developments in the Ophthalmic Lasers Market

  • In January 2024, Iridex launches next-generation platform Iridex 532 and Iridex 577 lasers in USA market
  • In January 2022, Alcon, the global leader in eye care completed the acquisition of Ivantis, Inc. The acquisition will help the company to strengthen its global ophthalmology portfolio.

Key Players of the Ophthalmic Lasers Industry

  • Abbott Medical Optics, Inc.
  • Alcon Inc. (Novartis AG)
  • Bausch & Lomb Incorporated
  • LENSAR, LLC
  • NIDEK CO., LTD
  • iVIS Technologies
  • ZEISS International
  • Ziemer Ophthalmic Systems AG
  • SCHWIND eye-tech-solutions GmbH & Co. KG.

Key Segments of the Ophthalmic Lasers Industry

By Product:

In terms of product, the industry is divided into excimer lasers and femtosecond laser.

By Application:

In terms of Application, the industry is divided into refractive surgery, cataract surgery, posterior capsulotomy, trabeculoplasty, and diagnostic.

By End User:

In terms of End Users, the industry is divided into hospitals (500 Bedded+, 250-499 Bedded, and Less than 250), ambulatory surgical centers, and ophthalmology clinics.

By Region:

Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

North America Vision Care Industry to Surpass USD 114,800.8 Million by 2033 at a 5.8% of CAGR, Amid Rising Demand for Eye Health Solutions

Vision Care Products in North America
Vision Care Products in North America

The vision care market in North America is expected to witness robust growth over the next decade, with demand projected to rise at a Compound Annual Growth Rate (CAGR) of 5.8% through 2033. The market is forecasted to grow significantly, increasing from an estimated valuation of US$ 65,326.3 million in 2023 to reach US$ 114,800.8 million by 2033.

This growth is driven by rising awareness of eye health, an aging population, and the increasing prevalence of vision-related issues, including myopia, presbyopia, and digital eye strain. Advances in vision care technologies, coupled with a growing emphasis on early diagnosis and treatment of eye conditions, are further contributing to market expansion.

Vision care products and services, including corrective lenses, contact lenses, and eye care solutions, continue to experience rising demand as consumers prioritize both vision health and lifestyle enhancement. This surge in demand underscores the vital role of innovative eye care solutions in improving quality of life across North America.

A Full Report Analysis – https://www.futuremarketinsights.com/reports/north-america-vision-care-market

Key Takeaways:

  • The North America vision care market is expected to grow from US$ 65,326.3 million in 2023 to US$ 114,800.8 million by 2033 at a CAGR of 5.8%.
  • Growth drivers include increased awareness of eye health, the aging population, and rising cases of vision impairments.
  • Advances in technology and heightened demand for corrective and preventive vision solutions are propelling the market.
  • Vision care products are essential for managing common conditions such as myopia, presbyopia, and digital eye strain.

With the increasing focus on comprehensive eye health solutions, the North American vision care market is positioned for significant advancements, delivering innovative products and services to meet evolving consumer needs.

Key Drivers of Market Growth

  1. Increasing Prevalence of Vision-Related Disorders: The rise in conditions such as myopia, hyperopia, and age-related eye diseases is driving demand for vision care services and products.
  2. Aging Population: As the population ages, the incidence of vision impairments increases, leading to greater demand for corrective eyewear and treatments.
  3. Technological Advancements: Innovations in vision care technology, including advanced lenses and treatment options, are enhancing the effectiveness of vision correction solutions.
  4. Emphasis on Preventive Eye Care: There is a growing focus on proactive eye health management among consumers and healthcare providers, which is fostering increased adoption of vision care services.
  5. Economic Factors: Rising disposable incomes and healthcare expenditures are enabling consumers to invest more in vision care products.

Market Insights

  • The market for vision care products in North America has shown robust growth, with historical sales reaching approximately USD 61,745.1 million in 2022, reflecting a CAGR of 7.6% from 2018 to 2022.
  • The leading product segment is expected to be Rx-Lenses, which accounted for about 47.1% of the market share in 2023.
  • Retail stores remain the primary distribution channel, capturing around 61.2% of the market share.

Competition Outlook for Vision Care Products in North America

The vision care industry in North America is highly competitive, with several key players vying for dominance. These companies offer a wide range of vision care products and services, including eyeglasses, contact lenses, intraocular lenses, and eye care surgery. They compete on several factors, including price, quality, convenience, and brand recognition.

The vision care product manufacturers are constantly innovating and developing new products and services to stay ahead of the competition. For example, EssilorLuxottica has recently invested heavily in the development of new eyeglass lens technologies, such as the Crizal Sapphire UV and Varilux X series. Johnson & Johnson Vision has also been active in innovation, with the recent launch of its Acuvue Vita contact lenses and its PrecisionID technology for LASIK surgery.

In addition to innovation, the key players in the vision care industry are also focused on expanding their distribution networks and making their products and services more accessible to consumers. For example, Warby Parker has recently opened several brick-and-mortar stores, and LensCrafters now offers online eye exams.

Challenges Faced by Key Players

  • The cost of vision care is rising, putting a strain on consumers’ budgets. This is leading to some consumers delaying or forgoing vision care altogether.
  • Online retailers such as Warby Parker and EyeBuyDirect offer consumers convenient and affordable access to vision care products. This is putting pressure on traditional brick-and-mortar retailers.
  • The aging population in North America is increasing the prevalence of age-related eye diseases such as cataracts and macular degeneration. This is driving demand for vision care services but also putting a strain on healthcare systems.

Recent Developments by Companies Offering Vision Care in North America:

  • EssilorLuxottica launched a new line of eyeglasses lenses called Crizal Sapphire UV. These lenses are designed to block UV rays, including harmful blue light.
  • Johnson & Johnson Vision launched a new contact lens called Acuvue Vita. This lens is designed to provide all-day comfort and hydration.
  • Alcon (Novartis) launched a new intraocular lens (IOL) called AcrySof IQ Vivity. This IOL is designed to provide patients with a broader range of vision without the need for glasses.
  • CooperVision launched a new contact lens called MyDay Toric. This lens is designed for patients with astigmatism and provides all-day comfort and hydration.
  • Bausch & Lomb launched a new contact lens solution called UltraONE. This solution is designed to clean, disinfect, and store contact lenses in one step.

Key Companies Providing Vision Care Products in North America

  • EssilorLuxottica
  • Johnson & Johnson Vision
  • Alcon (Novartis)
  • CooperVision
  • Bausch & Lomb
  • Warby Parker
  • LensCrafters
  • Visionworks
  • Pearle Vision
  • EyeBuyDirect
  • National Vision

Key Segments

By Product Type:

  • Rx-Lenses
  • Frames
  • Contact Lenses
  • Non-Rx Sunglasses
  • Reading Glasses
  • Contact Lens Solutions

By Distribution Channel:

  • Retail Stores
  • E-Commerce
  • Clinics
  • Hospitals

By Country:

  • The United States
  • Canada

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Prosthetic Heart Valve Industry to Reach USD 27,277.6 Million by 2033 at a 7.5% of CAGR, Driven by Rising Prevalence of Valvular Diseases

Prosthetic Heart Valve Market
Prosthetic Heart Valve Industry

The global prosthetic heart valve market is poised for significant growth, with a projected valuation of US$ 13,234.9 million in 2023, expected to more than double to US$ 27,277.6 million by 2033, according to the latest market analysis. This growth trajectory reflects a robust Compound Annual Growth Rate (CAGR) of 7.5% over the forecast period.

The increasing prevalence of valvular heart diseases, such as tricuspid regurgitation, idiopathic and ischemic mitral regurgitation, and aortic stenosis, is a key driver of this market expansion. Advances in prosthetic heart valve technologies and the growing adoption of minimally invasive procedures are further fueling demand.

Prosthetic heart valves are becoming an essential solution for managing complex cardiac conditions, offering improved patient outcomes and enhanced quality of life. As awareness about valvular illnesses and their treatment options continues to rise, healthcare providers are increasingly adopting these life-saving devices.

A Detailed Full Report – https://www.futuremarketinsights.com/reports/prosthetic-heart-valve-market

Key Takeaways:

  • The global prosthetic heart valve market is valued at US$ 13,234.9 million in 2023 and is projected to grow at a CAGR of 7.5%, reaching US$ 27,277.6 million by 2033.
  • The prevalence of valvular diseases such as tricuspid regurgitation, mitral regurgitation, and aortic stenosis is driving market demand.
  • Advances in technology and minimally invasive treatment options are boosting prosthetic heart valve adoption.
  • The industry is expected to witness sustained growth as awareness and diagnosis of valvular diseases increase globally.

With the global burden of cardiac conditions on the rise, the prosthetic heart valve market is well-positioned to deliver innovative solutions, ensuring better patient care and improved cardiac health outcomes.

Key Market Drivers

  1. Increasing Prevalence of Valvular Diseases: The rise in conditions such as tricuspid regurgitation, idiopathic and ischemic mitral regurgitation, and aortic stenosis is driving the demand for prosthetic heart valves.
  2. Minimally Invasive Procedures: The preference for stenting and other minimally invasive surgical options is increasing, as these procedures typically result in shorter recovery times and less postoperative discomfort compared to traditional surgeries.
  3. Technological Advancements: Innovations in prosthetic heart valve designs and materials are enhancing their efficacy and safety, making them more appealing to both healthcare providers and patients.
  4. Aging Population: As the global population ages, the incidence of cardiovascular diseases rises, leading to greater demand for heart valve replacements.
  5. Improved Healthcare Infrastructure: Enhanced healthcare facilities and increased access to advanced medical technologies in various regions are contributing to market growth.

Regional Insights

  • North America is expected to dominate the market due to its well-established healthcare infrastructure, high prevalence of cardiovascular diseases, and significant investments in research and development.
  • The region accounted for approximately 40.43% of the market share in 2023, driven by a high preference for prosthetic heart valve treatments among healthcare providers.

Competitive Analysis

Due to the aging population and the increased prevalence of cardiac illnesses, there is fierce rivalry in the sales of prosthetic heart valves. Prominent prosthetic heart valve manufacturers dominate the industry with a broad selection of products. Key research areas include advancements in biocompatibility, robustness, and minimally invasive methods.

New prosthetic heart valve suppliers are introducing modern technologies, and expanding markets in the Asia Pacific have room for expansion. Critical market share variables for prosthetic heart valves include cost-effectiveness, regulatory approvals, and market penetration techniques. The intense competition encourages constant innovations in artificial cardiac valve devices and better patient results.

Key Prosthetic Heart Valve Manufacturers

  • Edward Lifesciences Corporation
  • St. Jude Medical, Inc.
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • SYMETIS
  • LivaNova PLC
  • CryoLife, Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology, Inc.
  • Microinterventional Devices
  • Autotissue Berlin Gmbh
  • Meril Lifesciences
  • Comed B.V.

Key Segments

By Product:

  • Mechanical Heart Valves
    • Mechanical Aortic Valve
    • Mechanical Mitral Valve
  • Biological/Tissue Heart Valves
    • Tissue Aortic Valve
    • Tissue Mitral Valve
  • Transcatheter Heart Valves
    • Transcatheter Aortic Valve
    • Transcatheter Mitral Valve

By End User:

  • Hospitals
  • Ambulatory Services

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Prosthetic Heart Valve Market
Prosthetic Heart Valve Market

Coronary Stents Industry Set for Exponential Growth Driven by Rising Cardiovascular Cases and Minimally Invasive Solutions

Coronary Stents Industry
Coronary Stents Industry

According to the latest analysis by Future Market Insights (FMI), the demand for coronary stents, including portable variants, is expected to rise significantly in the coming years. Key factors driving this growth include the aging population and an increasing prevalence of cardiovascular diseases (CVDs), diabetes, obesity, and complex lesions. These risk factors underscore the critical role coronary stents play in modern cardiac care.

Coronary stents offer numerous benefits, including the enhancement of blood flow and prevention of further damage to the heart muscle. By alleviating symptoms of heart disease such as angina and shortness of breath, stents reduce the need for invasive coronary bypass surgeries. This makes stenting an attractive choice for surgeons and patients alike, as it is a minimally invasive procedure with relatively quick post-operative recovery times.

The growing acceptance of stenting as a preferred treatment method highlights its effectiveness in managing heart disease with lower surgical risks. As the global burden of heart-related conditions continues to escalate, innovative advancements in stent design and technology are poised to further improve outcomes, driving adoption and market growth.

A Comprehensive Full Report – https://www.futuremarketinsights.com/reports/coronary-stents-market

Key Takeaways:

  • The demand for coronary stents is set to grow exponentially, driven by an aging population and a rising prevalence of cardiovascular diseases, diabetes, and obesity.
  • Coronary stenting improves blood flow, mitigates heart muscle damage, and alleviates symptoms like angina and shortness of breath.
  • The procedure is a minimally invasive alternative to coronary bypass surgery, offering faster recovery times.
  • Surgeons increasingly prefer stents due to their efficacy and reduced patient risk.

As cardiovascular diseases remain a leading global health concern, the coronary stents market is positioned for sustained growth, transforming the way heart conditions are managed worldwide.

Key Drivers of Market Growth

  1. Increasing Prevalence of Cardiovascular Diseases: The growing incidence of conditions such as coronary artery disease (CAD), diabetes, and obesity is leading to a higher demand for coronary stenting procedures. This trend is particularly pronounced as these risk factors contribute significantly to heart-related ailments.
  2. Minimally Invasive Procedures: Stenting is favored by surgeons because it is a minimally invasive procedure that significantly improves blood flow, alleviates symptoms like angina and shortness of breath, and reduces the need for more invasive surgeries such as coronary bypass surgery.
  3. Technological Advancements: Innovations in stent technology, including bioresorbable vascular scaffolds and drug-eluting stents, are enhancing the effectiveness of treatments and expanding the range of applications for coronary stents.
  4. Hybrid Imaging Systems: The growing popularity of hybrid imaging systems that combine different modalities is anticipated to further boost market expansion by improving diagnostic accuracy and treatment outcomes.
  5. Government Initiatives: Increased government support and initiatives aimed at improving healthcare access are also contributing to market growth, particularly in regions with a high burden of cardiovascular diseases.
  6. Rising Healthcare Expenditures: As healthcare expenditures increase globally, there is greater investment in advanced medical technologies, including coronary stents, which supports market expansion.

Start-ups for Coronary Stents Market

Some key startups in the Coronary Stents market include-

  • Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedures for carotid artery disease. Their products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system. The ENROUTE Transcarotid Stent is intended to be used in conjunction with the Transcarotid Neuroprotection System (NPS) during the TCAR procedure. A small incision is made just above the collar bone to expose the common carotid artery in which a flexible sheath is placed directly into the carotid artery and connected to a system that will reverse the flow of blood away from the brain to protect against fragments of plaque.
  • Echopoint Medical is a leading developer of smart devices for monitoring coronary artery disease and microvascular dysfunction. The company is involved in the development of optical-fiber-based sensors that integrate into medical devices for monitoring cardiac health. It has developed its microcatheter device that uses nanomaterials and sensors that can be positioned into cardiovascular devices for detecting heart conditions by using iKOR technology.

Who are the Leading Players in the Coronary Stents Market?

The top Coronary Stents market players are constantly upgrading their offerings to help end users. They are investing in partnerships, acquisitions, collaborations, and new product launches to gain a competitive edge in the market. For instance:

  • In April 2021, Abbott announced the launch of the coronary imaging platform Ultreon 1.0 Software powered by Al in Europe. The software has been launched with the aim to improve the detection of calcium-based blockages and measuring vessel diameter during coronary stenting procedures.
  • In February 2021, Cardiovascular Systems Inc announced a partnership agreement with Chansu Vascular Technologies, LLC with an aim to develop peripheral and coronary drug-coated balloons for applications in drug-eluting stents.

Key Companies Profiled

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Biotronik
  • Stentys SA
  • MicroPort Scientific Corporation
  • C. R. Bard, Inc.
  • Cook Medical

Key Segments Covered in the Coronary Stents Industry Analysis

By Product:

  • Drug Eluting Stent (DES)
  • Bare Metal Stent (BMS)
  • Bioresorbable Vascular Stent (BVS)

By Raw Material:

  • Cobalt-Chromium
  • Stainless Steel
  • Platinum – Chromium
  • Nickel – Titanium
  • Polymer

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

By Region:

  • North America
  • Latin America
  • Brazil
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Cloud OSS BSS Market In Depth Analysis, Growth Strategies and Comprehensive Forecast 2022 to 2032

The cloud OSS BSS market revenues were estimated at USD 24 Billion in 2021 and are anticipated to grow at a CAGR of 8.4% from 2022 to 2032, according to a recently published Future Market Insights report. The market is expected to reach a valuation of USD 26.7 Billion in 2022 and US$ 60 Billion by the end of 2032. As more suppliers concentrate their investments on accelerating digital transformation, demand for Cloud OSS BSS is increasing.

For instance, in May 2021, EY and IBM announced the establishment of a Center of Excellence to aid financial institutions in accelerating their digital transformation through the use of hybrid cloud technologies. To assist clients in using the cloud at scale, the Center of Excellence is an integrated virtual center that provides services in digital trust, security, and regulatory compliance.

The technology helps telecom network back-office activities while retaining customer service. Information processing systems are frequently used by operators to manage their communications networks. It supports operators in the creation, edification, and maintenance of communication networks.

Modern OSS and BSS may assist businesses in anticipating market trends, enhancing customer happiness, boosting operational effectiveness, and gaining market and operational insights from big data.

The impact of Covid-19 on the Cloud OSS BSS Market:

Significant adjustments have been made to people’s routines, workplaces, and surroundings as a result of the COVID-19 outbreak. This is because operators can deal with the bandwidth issues brought upon by the pandemic with these technologies. In addition, consumers will expect consistent bandwidth as regulations supporting remote work, video conferencing, and distance learning become increasingly common.

By the beginning of May 2020, AT&T forecasts a 75% increase in gaming traffic, a significant increase in call volume, and a 33% increase in call time. As a result, telecom operators are updating their OSS BSS systems to keep up with the evolving needs of their customers. The outbreak will probably present the OSS & BSS sector with alluring opportunities.

For instance, MATRIXX Software declared in June 2020 that AT&T Mexico, an AT&T subsidiary, would introduce the cloud-native digital commerce platform of MATRIXX Software for its prepaid customers. In order to deliver a web-scale BSS that will increase business agility and innovation, MATRIXX Digital Commerce has replaced various legacy Corporate Support Systems as well as the Intelligent Network.

Competitive Landscape:

Players in the market are constantly developing improved analytical solutions as well as extending their product offerings. The companies in the Cloud OSS BSS market are focused on alliances, technology collaborations, and product launch strategies.

Some of the recent developments of key Cloud OSS BSS providers are as follows:

In November 2021, Vonage Holdings, a provider of cloud-based communications agreed to be acquired by Ericsson. In order to provide the framework for the establishment of industry business, the organization sought to create dominant mobile networks through technological leadership. In terms of providing consumers with a platform to monetize network investments, Vonage is also the most current innovation, assisting businesses and developers.

In June 2021, CES 21, Amdocs announced that the latest edition of its cloud-based OSS-BSS integrated suite, has been released. It will help service providers to build, deploy, and monetize novel services by leveraging investments in technologies such as 5G standalone networks, AI, MEC, SDN, ML, and the cloud.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Occupancy Sensor Market to Generate Total Revenue of US$ 6,558.9 Million in 2032 Attributing to the Surge in Technology-Enabled Smart Products Globally

The global occupancy sensor market is anticipated to grow at a phenomenal CAGR of around 12% during the forecast period from 2022 to 2032. The global market is expected to hold a valuation of around USD 2,115.6 Million in 2022 and is expected to secure a valuation of USD 6,558.9 Million in 2032. According to the analysis done by Future Market Insights in the historic period from 2016 to 2021, the global occupancy sensor market displayed a growth rate of 9.8%.

Future Market Insights, Inc., Wednesday, December 7, 2022, Press release picture

The growth of the market is attributed to the increased demand for occupancy sensors, which are primarily utilized for security purposes to prevent break-ins, burglaries, and thefts, the occupancy sensor market is growing. Furthermore, green buildings are becoming more and more common all over the world, which is anticipated to lead to market growth of occupancy sensors in the market.

An occupancy sensor is also known as a vacancy sensor. It is a device that is used to detect whether the room is occupied or not and allows the user to turn up or down the equipment accordingly. The occupancy sensor works in conjunction with ultrasonic rays, microwave technology, and infrared light rays to detect occupancy in a building and adjust the lighting appropriately based on the lack of occupancy.

This sensor detects occupation using infrared, ultrasonic, or microwave technologies. Occupancy sensors are most commonly utilized in specific areas where automation, energy conservation, and building code compliance are required the most. Various technological advances in the industry have led to the development of occupancy sensors in response to the growing demand for energy-saving devices.

This type of indoor detecting mechanism helps in altering the air temperature and ventilation within a particular area in response to the presence of individuals. Apart from stairwells, open and closed offices, corridors, and warehouses, they also find applications in residential, commercial, and industrial spaces. Additionally, occupancy sensors assist in automating motor load switching on fans, curtains, air conditioners, and a variety of other devices run by motors.

Key Takeaways

  • Sensors might falsely trigger when some movement in the space is observed. Due to their sensitivity to a wide range of motion, they also react to certain movements that are not related to occupants. False triggers are expected to occur because of sunlight shining on the sensor, persons passing close to it, or machinery heating objects that are positioned nearby. Similarly, sensors do not work well within the partitioned offices. Lighting systems and other components that are connected to them have a much shorter life expectancy if sensors are continuously on and off.

  • The surging popularity of energy-efficient sensors is one of the crucial factors that have a positive contribution to the global occupancy sensor market’s growth. With stringent government policies pertaining to energy savings and the persistent advancement of high-tech and cost-efficient occupancy sensors, the global occupancy sensor market is expected to expand over the forecast period.

  • The global occupancy market has recently surged with advanced occupancy sensors including intelligent occupancy sensors, image-processing occupancy sensors, and microphonics. Increasingly, lighting controllers are gaining immense traction which is positively affecting the growth of the occupancy sensor market. Furthermore, under the present technological landscape, dominant market players within the occupancy sensor market are expected to experience high growth opportunities in the coming years.

  • Furthermore, the rising development of smart cities has been witnessed to be a major factor that encourages growth in the economy. Being a part of intelligent parking solutions, these sensors are utilized to minutely monitor parking spaces and control congestion. Occupancy sensors must be implemented both indoors and outdoors to minimize energy consumption and light pollution created in the environment. As a result, all of these factors contribute to the market growth of occupancy sensors.

Read Full Report @
https://www.futuremarketinsights.com/reports/occupancy-sensor-market

Competitive Landscape
Dominant market players are developing a massive range of technologically advanced and innovative sensors in order to gain a long-term competitive advantage, such as image processing sensors, microphonic sensors, and intelligent occupancy sensors.

More Insights into the Occupancy Sensor Market

North America is anticipated to dominate the global occupancy sensor market by accounting for the largest market share. The North American region comprises higher growth prospects for occupancy sensors for commercial and residential buildings than any other region in the world. As of 2022, occupancy sensors are expected to account for 38% of the market in these regions.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

PET Scanner Industry to Surpass USD 2.1 Billion by 2033 at a 5.3% of CAGR, Driven by Rising Disease Prevalence and Technological Advancements

Positron Emission Tomography (PET) Scanners Industry
PET Scanner Industry

The global positron emission tomography (PET) scanners market is projected to grow significantly over the next decade, increasing from an estimated USD 1.3 billion in 2023 to USD 2.1 billion by 2033, according to the latest market analysis. This growth represents a robust Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.

The rise in adoption of PET scanners is attributed to the increasing prevalence of diseases such as cancer, Alzheimer’s, and other critical conditions. Hospitals and healthcare facilities are expanding their use of PET scanners to accurately detect both malignant and non-malignant tumors. In particular, PET technology has proven instrumental in diagnosing various cancers, including breast, lung, thyroid, ovarian, cervical, and neck cancers, further solidifying its role in modern diagnostic medicine.

In addition to its clinical applications, the PET scanner market is witnessing growth due to advancements in hybrid imaging systems that combine PET with complementary modalities, such as CT and MRI. Furthermore, the introduction of silicon photomultiplier (SiPM) technology and TSPO PET tracers are setting new benchmarks in imaging precision and efficiency. These innovations, coupled with stringent government regulations and the entry of new market players, are anticipated to drive market expansion.

Get Full Report Now – https://www.futuremarketinsights.com/reports/positron-emission-tomography-scanners-market

Key Takeaways:

  • The PET scanners market is estimated at US$ 1.3 billion in 2023 and is projected to reach US$ 2.1 billion by 2033.
  • CAGR: 5.3% from 2023 to 2033.
  • Growing prevalence of diseases like cancer and Alzheimer’s is a significant demand driver.
  • Advancements in hybrid imaging systems and SiPM technology are key contributors to market growth.
  • Increased adoption in hospitals for detecting a wide range of cancers is accelerating market expansion.

As healthcare providers prioritize precise and early diagnostics, the positron emission tomography (PET) scanner market is set to play a critical role in revolutionizing patient care worldwide.

Key Market Drivers

  1. Increasing Prevalence of Diseases: The rising incidence of conditions such as cancer and Alzheimer’s disease is significantly driving the adoption of PET scanners for accurate diagnosis and monitoring.
  2. Demand from Hospitals: There is a growing need for PET scanners in hospitals for detecting both malignant and non-malignant tumors, which enhances the market’s growth prospects.
  3. Hybrid Imaging Systems Popularity: The increasing popularity of hybrid imaging systems, such as PET/CT and PET/MRI, is expected to boost market expansion due to their enhanced diagnostic capabilities.
  4. Technological Innovations: Advancements in technology, including the development of silicon photomultiplier (SiPM) technology and new PET tracers like TSPO, are contributing to the growth of the PET scanner market.
  5. Regulatory Support and New Entrants: Stringent government regulations ensuring safety and efficacy, along with new market entrants introducing innovative solutions, are further propelling market growth.

Competitive Landscape

Key players focus on novel and innovative approaches to develop positron emission tomography scanners. Production facility expansions, new product launches, and product approvals can strengthen their market presence

Some of the prominent players in the market are:

Recent Developments in the Positron Emission Tomography (PET) Scanners Market

  • In March 2021, the USA FDA gave clearance to Siemens Healthineers’ Biograph Vision Quadra, a new PET/CT scanner with a large 106 cm axial field of view.
  • In July 2021, G.E. healthcare collaboration with Quibim, Oncovision, and Full Body Insight to innovate PET/CT total-body scanners for whole-body imaging.
  • In May 2021, G.E. Healthcare acquired Zionexa to scale Zionexa’s FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18). The product is used as an adjunct to biopsy to detect estrogen receptor (E.R.) positive lesions. It helps to assist healthcare providers in treatment selection for patients with recurrent or metastatic breast cancer.

Positron Emission Tomography (PET) Scanners Market by Category

By Product Type:

  • Full-ring PET Scanner
  • Partial-ring PET Scanner

By Application:

  • Oncology
  • Cardiology
  • Neurology
  • Others

By Detector Type:

  • Bismuth Germanium Oxide
  • Lutetium Oxyorthosilicate
  • Gadolinium Oxyorthosilicate
  • Lutetium Fine Silicate
  • Lutetium Yttrium Orthosilicate

By End User:

  • Hospitals
  • Diagnostic Centers
  • PET Centers
  • Research Institute

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

GCC Medical Glove Industry to Reach USD 213.7 Million by 2034 at a 2.3% of CAGR, Amid Rising Focus on Hygiene Practices

GCC medical glove
GCC Medical Glove Industry

The GCC medical glove industry is poised for steady growth, with an estimated market value of US$ 170.3 million in 2024, according to a recently updated industry analysis report. The heightened focus on maintaining stringent hygiene standards in healthcare settings across the Gulf Cooperation Council (GCC) region is anticipated to be a primary driver of increasing demand for medical gloves.

The report highlights that the sector is expected to grow at a moderate Compound Annual Growth Rate (CAGR) of 2.3% over the next decade, reflecting consistent demand in response to the evolving needs of healthcare institutions. With a growing emphasis on infection control and patient safety, the market is projected to reach US$ 213.7 million by 2034, underscoring its pivotal role in supporting GCC healthcare infrastructure.

Industry experts attribute this growth to the rising awareness about the importance of disposable medical supplies in minimizing cross-contamination risks. Key stakeholders, including hospitals and clinics, are amplifying their procurement of gloves to adhere to international hygiene protocols, further fueling market expansion.

A Full Report Overview – https://www.futuremarketinsights.com/reports/gcc-medical-gloves-market

Key Takeaways:

  • The GCC medical glove industry is valued at US$ 170.3 million in 2024.
  • Market growth is forecasted at a CAGR of 2.3% over the next decade.
  • The industry’s valuation is expected to reach US$ 213.7 million by 2034.
  • Hygiene awareness and infection control measures are driving increased demand.

With hygiene practices continuing to be a top priority for the GCC healthcare sector, the medical glove industry is set to play a crucial role in safeguarding health standards across the region.

Key Insights on the Medical Glove Sector of GCC

  • The key trends include the production of biodegradable nitrile gloves to address the growing problem of medical waste disposal. The inustry is subject to be influenced by product regulations and raw material supply, as per industry and macroeconomic dynamics.
  • Medical glove manufacturers in the Gulf region are focusing more on mergers and acquisitions to expand their production capacity to meet the growing demand. For instance, Top Glove, a leading Malaysian glove manufacturer acquired Aspion in January 2018. The acquisition has increased its production capacity of 4.77 billion pieces of gloves in one year and 75 new lines.

Competitive Landscape for GCC Medical Glove Industry

The overall industry is currently moderately competitive as there are a few manufacturers operating at scale in different Gulf countries.

Companies operating in the medical gloves industry are aiming to strengthen their position through partnerships, collaborations, mergers & acquisitions, and agreements with established players, and other healthcare institutions. In addition to this, governments in GCC countries are increasing their investments in the expansion of the healthcare sector, which in turn is encouraging the emergence of new regional players.

Recent Developments in the GCC Medical Glove Industry

In January 2021, Medline Industries announced a strategic partnership with the University of California, Davis / UC Davis. Students returning to the campus were provided custom PPE kits to be worn to avoid the spread of the COVID-19 virus. This way awareness and education among the peers were spread to reduce the strain on healthcare professionals.

Kimberly-Clark Corporation introduced the Kimtech Opal Nitrile Gloves in February 2022, with the purpose of guarding against microbiological and chemical splash dangers. These innovative gloves don’t include latex or vulcanizing chemicals, which reduces the possibility of skin responses related to Type I and Type IV allergies

Key Players Profiled in the GCC Medical Glove Industry Report

  • Paul Hartmann AG
  • Hotpack Packaging Industries LLC
  • Falcon (Falcon Pack)
  • Deeko Bahrain
  • Salalah Medical Supplies Mfg. Co. LLC
  • United Medical Industries
  • NAFA Enterprises Ltd.
  • Liberty Industries, Inc.
  • Ansell Healthcare
  • Mckesson Corporation
  • Cardinal Health, Inc.
  • Medline Industries, Inc.
  • Dynarex Corporation
  • Top Glove Corporation Berhad
  • Kimberly-Clark Corporation
  • Semperit AG Holding

Key Segments Covered by GCC Medical Glove Industry Survey Report

By Raw Material:

  • Latex
  • Nitrile Rubber
  • Vinyl Rubber
  • Polyisoprene
  • Other Materials

By Product Type:

  • Examination
  • Surgical
  • Chemotherapy

By Form:

  • Powdered form Gloves
  • Powder-free form Gloves

By Type of Use:

  • Disposable Gloves
  • Re-usable Gloves

By End User:

  • Hospital Use
  • Clinic Use
  • Ambulatory Surgery Centre Use
  • Diagnostic Imaging Centre Use
  • Rehabilitation Centre Use

By Distribution Channel:

  • Direct Selling Channel
  • Medical Store Channel
  • E-Commerce Channel
  • Other (Retail Store or Hypermarket) Channel

By Countries:

  • Kingdom of Saudi Arabia (KSA)
  • United Arab Emirates (UAE)
  • Qatar
  • Bahrain
  • Oman
  • Kuwait

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hypercalcemia Treatment Industry to Triple in Value by 2033, Reaching USD 55.07 Billion at a 11.8% of CAGR

Hypercalcemia Treatment Market
Hypercalcemia Treatment Market

The global market for hypercalcemia treatment is poised for substantial growth, with a valuation of USD 18.07 billion in 2023. Exhibiting a remarkable CAGR of 11.8% over the forecast period (2023–2033), the market is projected to reach an impressive valuation of USD 55.07 billion by 2033.

Key Growth Factors:

  1. Rising Incidence of Hypercalcemia
    The increasing prevalence of hypercalcemia-related conditions, such as malignancy-associated hypercalcemia and parathyroid disorders, is a significant driver for market growth.
  2. Advancements in Treatment Modalities
    Innovations in therapeutic options, including calcimimetic agents, bisphosphonates, and biologics, are driving the adoption of effective hypercalcemia management strategies.
  3. Growing Awareness and Diagnostics
    Improved awareness of hypercalcemia’s complications and advancements in diagnostic technologies are enabling early detection and treatment, contributing to market expansion.
  4. Increasing Healthcare Investments
    Rising healthcare expenditures globally and an aging population are fueling demand for hypercalcemia treatment options, particularly in developed and emerging markets.

Get Full Report Now – https://www.futuremarketinsights.com/reports/hypercalcemia-treatment-market

Regional Insights:

North America remains the dominant market due to well-established healthcare systems and high awareness. Meanwhile, the Asia-Pacific region is anticipated to witness the fastest growth, fueled by expanding healthcare access and increasing disease burden.

Future Outlook:

The hypercalcemia treatment market is expected to flourish with continued advancements in targeted therapies, personalized medicine approaches, and increasing focus on improving patient outcomes.

Competitive Landscape

Companies indulged in developing hypercalcemia drugs and treatment therapies are actively seeking to strengthen their position through approval, and agreements with established healthcare institutes. Also, collaborations, mergers & acquisition partnerships with regional players can accelerate their strategy to capture a significant share of the emerging markets.

The emergence of many biotech firms for conducting research and development on hypercalcemia diagnosis and therapy also could be a factor for further market growth. They are developing medicines and APIs manufactured in individual and combination doses for the treatment of hypercalcemia associated with thyroid tumors and other illnesses.

Key Developments

  • In April 2021, Novartis AG announced a collaboration with Artios Pharma. This collaboration was made to improve both companies’ discovery platforms, leverage their knowledge, and improve the potential of radio ligand therapies for treating cancers of both companies.
  • In June 2021, Bayer AG and Aurexel Life Sciences published their collaborative article reports where they announced promising results with the use of combination therapy of radium-223 and bortezomib. It was used for treating multiple myeloma bone disease.
  • In September 2021, Sunovian Pharmaceuticals announced a joint development and collaboration with Otsuka Pharmaceutical Co. This collaboration was made as an effort to improve the research and development activities to improve their production of novel drug compounds.
  • In January 2021, Bayer AG announced the USA FDA priority review for their New Drug Application for Finerenone drug used to treat patients with chronic kidney disease and associated Type 2 diabetes.

Key Companies Profiled

  • Amgen Inc.
  • Pfizer Inc.
  • Mylan N. V.
  • Sunovion
  • Procter And Gamble
  • Apotex Corporation
  • Genentech, Inc.
  • Novartis AG
  • Bayer AG
  • Hoffmann La Roche
  • Atnahs Pharma
  • Cipla Inc.
  • Sun Pharmaceuticals Industries Ltd
  • Dr. Reddy’s Laboratories
  • Aurobindo Pharma Limited

Key Market Segments Covered In Hypercalcemia Treatment Industry Research

By Product:

  • Bisphosphonates
    • Clodronate
    • Ibandronate
    • Pamidronate
    • Zoledronic Acid
  • Calcitonin
  • Glucocorticoids
  • Denosumab
  • Calcimimetics

By Distribution Channel:

  • Hospitals
  • Clinics
  • Independent Pharmacy & Drug Stores

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

GCC Syringes and Needles Industry Set for Robust Growth, Projected to Reach USD 1,164.90 Million by 2034 at a 5.40% of CAGR

GCC Syringes and Needles Market
GCC Syringes and Needles Industry

The market for syringes and needles in the GCC (Gulf Cooperation Council) region is expected to experience steady growth over the coming decade, driven by advancements in healthcare infrastructure, increasing prevalence of chronic diseases, and growing demand for modern medical devices.

Sales of syringes and needles in GCC are projected to grow at a CAGR of 5.40% from 2024 to 2034, with the market valuation estimated to rise from USD 688.5 million in 2024 to USD 1,164.9 million by 2034.

A Full Report Overview – https://www.futuremarketinsights.com/reports/gcc-syringes-and-needles-market

Key Growth Drivers:

  1. Healthcare Advancements: Enhanced healthcare services and the adoption of cutting-edge medical technologies in GCC nations are boosting the demand for syringes and needles.
  2. Chronic Disease Management: The increasing prevalence of diabetes, cardiovascular diseases, and other chronic conditions necessitates frequent injections and blood draws, driving market growth.
  3. Vaccination Programs: Expanded immunization programs across the GCC, including COVID-19 vaccination campaigns, are contributing to higher demand.
  4. Rising Medical Tourism: The GCC’s reputation as a hub for quality healthcare services is further augmenting the need for syringes and needles.

Key Insights – Highlights on the Emerging Opportunities in the GCC Syringe and Needle Industry

  • GCC countries, specifically Saudi Arabia and the United Arab Emirates, are becoming popular travel destinations for medical tourists looking for high-quality medical care. Manufacturers of syringes and needles can boost revenues by providing top-notch medical equipment to clinics and hospitals that treat patients worldwide. This will help in broadening their global reach.
  • Manufacturers can satisfy the particular demands of pediatric and geriatric patients by developing age-appropriate injectable devices with safety features, ergonomic designs, and possibilities for dose modification. This can address an unmet demand and improve patient satisfaction and compliance.
  • The GCC region is witnessing a rise in biological medicines and the prevalence of chronic illnesses. This presents a potential for manufacturers to deliver specialty syringes and needles designed specifically for the administration of more complex pharmaceuticals.

Competitive Landscape

The syringe and needle industry in the GCC region is extremely competitive, with numerous established global businesses competing alongside regional players. Becton, Dickinson, and Company (BD) is an industry leader, relying on its large product range, robust distribution network, and sterling reputation to stay ahead.

Terumo Corporation, Smiths Medical, and Nipro Corporation constitute the top rivals contending for industry share, with each offering a varied selection of syringes and needles tailored to different medical specializations and uses.

Recent Developments

  • In February 2023, Venus Remedies Ltd., a leading research-based pharmaceutical company, received a good manufacturing practices (GMP) certification from Saudi Arabia.
  • In September 2022, BD (Becton, Dickinson, and Company), a renowned worldwide medical technology firm, launched a next-generation glass pre-fillable syringe (PFS) that sets a new benchmark for vaccine PFS performance, with new and tighter criteria for processability, cosmetics, contamination, and integrity.

Key Players in the Syringe and Needle Industry in GCC

  • Becton, Dickinson and Company (BD)
  • Terumo Corporation
  • Smiths Medical
  • Nipro Corporation
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Gerresheimer AG
  • Hindustan Syringes & Medical Devices Ltd. (HMD)
  • Medtronic plc
  • Fresenius SE & Co. KGaA

Key Segments

By Product:

  • Oral
  • Hypodermic
    • Standard
    • Special Purpose
      • Insulin
      • Tuberculin
      • Other Special Purpose
      • Angiographic

By Usability:

  • Disposable
  • Reusable

By Material:

  • Glass
  • Polymer

By End User:

  • Hospital
  • Blood Collection Center
  • Diabetic Care Center
  • Veterinary Care Center
  • Others

By Country:

  • Kingdom of Saudi Arabia (KSA)
  • United Arab Emirates (UAE)
  • Qatar
  • Bahrain
  • Oman
  • Kuwait

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube